Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 1426-1430, March 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marquardt, D.
Right arrow Articles by Center, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marquardt, D.
Right arrow Articles by Center, M. S.

Mechanisms of Multidrug Resistance in HL60 Cells: Detection of Resistance-associated Proteins with Antibodies against Synthetic Peptides That Correspond to the Deduced Sequence of P-Glycoprotein1

David Marquardt, Sue McCrone and Melvin S. Center2

Division of Biology, Kansas State University, Manhattan, Kansas 66506

HL60 cells isolated for resistance to Adriamycin are multidrug resistant and defective in the cellular accumulation of drug. These cells do not however overexpress mdr1 and do not contain detectable levels of P-glycoprotein. In the present study we have prepared antisera against synthetic peptides that correspond to various sequence domains of P-glycoprotein and have examined by Western blot analysis the reactivity of these antisera with proteins contained in membranes of HL60/Adr cells. All antisera are highly reactive with a Mr 180,000 (p180) P-glycoprotein contained in membranes of HL60 cells isolated for resistance to vincristine (HL60/Vinc). In contrast, of 13 antisera tested 12 do not react with any resistance-associated protein in the HL60/Adr isolate. One antiserum (ASP14) is however highly reactive with a Mr 190,000 protein (p190) contained in HL60/Adr membranes. This protein is not detected in drug-sensitive cells. ASP14 also reacts with proteins p195 and p50 contained in a second independent HL60/Adr isolate. Analysis of membrane subfractions shows that p190 is located primarily in the endoplasmic reticulum with only low levels contained in plasma membranes. Additional studies demonstrate that endoplasmic reticulum of HL60/Adr cells contain a major Mr 190,000 protein that is capable of binding the photoaffinity agent 8-azido[{alpha}-32P]ATP. p195 contained in a second HL60/Adr isolate is also labeled with 8-azido[{alpha}-32P]ATP.

These results thus demonstrate that antiserum against a specific P-glycoprotein sequence detects a p190 (p195) resistance-associated membrane protein in two independent HL60/Adr isolates. p190 (p195) and P-glycoprotein thus contain a minor sequence homology and based on the specificity of ASP14 this occurs in a region which may be involved in nucleotide binding. Possibly this sequence is common to and essential for the functionality of proteins which contribute to resistance by reducing cellular drug levels.

1 This investigation was supported by Research Grant CA-37585 from the National Cancer Institute, Department of Health and Human Services, and by a grant from Bristol-Myers.

2 To whom requests for reprints should be addressed.

Received 8/17/89. Revised 11/ 8/89. Accepted 11/27/89.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. Rius, J. Hummel-Eisenbeiss, and D. Keppler
ATP-Dependent Transport of Leukotrienes B4 and C4 by the Multidrug Resistance Protein ABCC4 (MRP4)
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 86 - 94.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Rajagopal and S. M. Simon
Subcellular Localization and Activity of Multidrug Resistance Proteins
Mol. Biol. Cell, August 1, 2003; 14(8): 3389 - 3399.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. Lee, A. J. P. Klein-Szanto, and G. D. Kruh
Analysis of the MRP4 Drug Resistance Profile in Transfected NIH3T3 Cells
J Natl Cancer Inst, December 6, 2000; 92(23): 1934 - 1940.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Zeng, G. Liu, P. A. Rea, and G. D. Kruh
Transport of Amphipathic Anions by Human Multidrug Resistance Protein 3
Cancer Res., September 1, 2000; 60(17): 4779 - 4784.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
H. Zeng, L. J. Bain, M. G. Belinsky, and G. D. Kruh
Expression of Multidrug Resistance Protein-3 (Multispecific Organic Anion Transporter-D) in Human Embryonic Kidney 293 Cells Confers Resistance to Anticancer Agents
Cancer Res., December 1, 1999; 59(23): 5964 - 5967.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-S. Chen, K. Lee, and G. D. Kruh
Transport of Cyclic Nucleotides and Estradiol 17-beta -D-Glucuronide by Multidrug Resistance Protein 4. RESISTANCE TO 6-MERCAPTOPURINE AND 6-THIOGUANINE
J. Biol. Chem., August 31, 2001; 276(36): 33747 - 33754.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.